Benefiting from the advantages of scRNA-seq technology, we could perform a high-resolution dissection of interactions among various subgroups of CTNND1+/- tumor cells and microenvironment subpopulation in the NSCLC patients based on the combining expression of multi-subunit ligand-receptor complexes. This evidence concerns the gene CTNND1 and neoplasm.